Leidos Stock Drops After Bank of America Downgrades Price Target
Leidos stock fell by 11% after Bank of America downgraded its rating from 'buy' to 'neutral' and cut the price target. The firm cited concerns over pressure on Leidos's healthcare portfolio, particularly due to changes in how the Defense Health Agency operates.
Topics: Bank of America healthcare portfolio Leidos price target cut